期刊文献+

新生儿疾病筛查人群中CYP21基因P30L和V281L突变携带者频率的研究

Carrier frequency of CYP21 gene with P30L and V281L mutation in neonatal screening population
下载PDF
导出
摘要 目的研究新生儿疾病筛查人群中CYP21基因P30L和V281L突变杂合子的频率分布。方法58份新生儿干血滤纸片测定17—OHP,同时提取新生儿脐带血DNA,应用PCR扩增和限制性内切酶分析P30L和V281L两种与21-OHD相关的CYP21基因突变,计算杂合子频率。结果在116个等位基因中有1个鉴定出P30L突变,未鉴定出V281L突变。本研究人群中P30L的携带者频率为0.9%,V281L的携带者频率为0。结论本研究新生儿筛查正常人群中可检出CYP21基因突变携带者,对人群中CYP21基因突变携带者的研究有助于对漏检21-OHD的基因突变分析。 Objective To study carrier frequency of CYP21 gene mutations in neonatal screening population. Method 17-OHP on 58 neonatal dry blood filters for screening were detected. DNAs of each umbilical cord blood were extracted, PCR and restriction endonucleases were used to identify the P30L and V281L mutations. Result One P30L mutation were found in 116 alleles, and no V281L. Carrier frequencies of P30L and V281L were 0.9% and 0% in this population. Conclusion The observed CYP21 mutation carrier frequency in screening negative population suggests which would be relative with the 21-OHD missed in the neonatal screening.
出处 《国际医药卫生导报》 2008年第14期8-10,共3页 International Medicine and Health Guidance News
基金 广东省医学科研基金立项课题(A2007569)
关键词 携带者频率 CYP21基因 新生儿疾病筛查 carrier frequency CYP21 neonatal screening
  • 相关文献

参考文献6

  • 1White PC and Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency[J].Endocrine Reviews, 2005,21(3): 245-291
  • 2叶军,顾学范.新生儿疾病筛查[M].上海科学技术出版社.2003,185-198
  • 3van der Kamp HJ and Wit JM. Neonatal screening for congenital adrenal hyperplasia[J].European Journal of Endocrinology, 2004,151:U71-U75
  • 4Baumgartner-Parzer SM, Nowotny P, Heinze G, et al. Carrier Frequency of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in a Middle European Population[J].J Olin Endocrinol Metab, 2005, 90 (2): 775-778
  • 5张波,陆召麟,王玥,陶红.中国人21-羟化酶缺乏症基因型和临床表型特点研究[J].Acta Genetica Sinica,2004,31(9):950-955. 被引量:17
  • 6Related Articles, Shinagawa T, Horikawa R, et al. Nonclassic steroid 21-hydroxylase deficiency due to a homozygous V281L mutation in CYP21A2 detected by the neonatal mass-screening program in Japan [J].Endocr J, 2007;54(6):1021-1025

二级参考文献7

  • 1Asanuma A,Ohura T,Ogawa E.Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency.J Hum Genet,1999,44(5): 312-317.
  • 2Yokoyama Y,Teraoka M,Tsuji K.Rapid screening method to detect mutation in CYP21,the gene for 21-hydroxylase.Am J Med Genet,2000,94(1): 28-31.
  • 3Balsamo A,Cacciari E,Baldazzi L.CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region.Clin Endocrinol (Oxf),2000,53(1): 117-125.
  • 4Tajima T,Fujieda K,Nakae J.Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan.Endocr J,1998,45(4): 493-497.
  • 5Perrin C W ,Phyllis W S.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Endocr Rev,2000,21 (3): 245-291.
  • 6Jaaskelainen J,Levo A,Voutilainen R,Partanen J.Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population.J Clin Endocrinol Metab,1997,8
  • 7廖相云,张雅芬,顾学范.21-羟化酶缺乏症患者CYP21基因点突变研究[J].中华儿科杂志,2003,41(9):670-674. 被引量:23

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部